EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activation of EZH2 Promoter Is Mediated by MAPK Signaling Regulated Transcription Factors in Anaplastic Thyroid Cancer

Marcella Maringolo Cristovão iD, Diego Claro de Mello iD, Edna Teruko Kimura iD, Cesar Seigi Fuziwara iD

International Journal of Molecular Sciences · 18.07.2026 · 27 (14) · 6402

DOI: 10.3390/ijms27146402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.07.2026. Verfasst von Marcella Maringolo Cristovão und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo 05508-000, SP, Brazil. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Enhancer of Zeste Homolog 2 Protein, Promoter Regions, Genetic, Thyroid Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Sao Paulo Research Foundation—FAPESP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaplastic thyroid carcinoma (ATC) is the most aggressive thyroid cancer type harboring TP53, TERT promoter and MAPK signaling alterations. Additionally, EZH2 overexpression leads to epigenetic silencing of tumor suppressor and cell differentiation genes. Here, we investigate the mechanism of EZH2 transcriptional activation in ATC. We used several luciferase reporter constructs with deletion of transcription factor (TF) binding sites identified in silico to determine EZH2 minimal promoter in ATC. MAPK signaling blockage with U0126, TF overexpression and knock-down strategies were used to evaluate EZH2 expression and reporter plasmid response, and the cross talk with TFs. As a result, we observed that EZH2 transcription is regulated by a minimal promoter of 107 bp (E3/4 region), that contains binding sites for TF NFYA, YY1 and FOXM1, highly expressed in ATC, that when deleted reduced EZH2 promoter activation. MAPK blockage reduced EZH2 and influenced YY1 and FOXM1 TF levels, while overexpression of NFYA, YY1 and FOXM1 resulted in pro-tumoral effects and EZH2 upregulation in papillary thyroid cancer cells. On the other hand, FOXM1 knock-down reduced EZH2 activation in ATC cells. Thus, we identified the minimal promoter region essential for EZH2 activation in ATC that is controlled by MAPK signaling in crosstalk with TFs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Carcinoma, AnaplasticEnhancer of Zeste Homolog 2 ProteinPromoter Regions, GeneticThyroid NeoplasmsMAP Kinase Signaling SystemHumansGene Expression Regulation, NeoplasticCell Line, TumorYY1 Transcription FactorForkhead Box Protein M1CCAAT-Binding FactorBinding SitesTranscriptional ActivationTranscription Factors

Stichwörter der Autor:innen

EZH2MAPK signalinganaplastic thyroid cancerpromoter regiontranscription factorstranscriptional control

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanYY1 Transcription FactorForkhead Box Protein M1CCAAT-Binding FactorYY1 protein, humanNFYA protein, humanFOXM1 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo 05508-000, SP, Brazil.
  • Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo 04044-020, SP, Brazil.

ORCID-Profile: Marcella Maringolo Cristovão, Diego Claro de Mello, Edna Teruko Kimura, Cesar Seigi Fuziwara

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Sao Paulo Research Foundation—FAPESP
  • National Council for Scientific and Technological Development—CNPq

Zitieren

APA

Cristovão, M. M., de Mello, D. C., Kimura, E. T., & Fuziwara, C. S. (2026). Activation of EZH2 Promoter Is Mediated by MAPK Signaling Regulated Transcription Factors in Anaplastic Thyroid Cancer. International Journal of Molecular Sciences, 27(14), 6402. https://doi.org/10.3390/ijms27146402

Vancouver

Cristovão MM, de Mello DC, Kimura ET, Fuziwara CS. Activation of EZH2 Promoter Is Mediated by MAPK Signaling Regulated Transcription Factors in Anaplastic Thyroid Cancer. International Journal of Molecular Sciences. 2026;27(14):6402. doi:10.3390/ijms27146402

BibTeX
@article{Cristovo2026,
  author = {Cristovão, Marcella Maringolo and de Mello, Diego Claro and Kimura, Edna Teruko and Fuziwara, Cesar Seigi},
  title = {Activation of EZH2 Promoter Is Mediated by MAPK Signaling Regulated Transcription Factors in Anaplastic Thyroid Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6402},
  doi = {10.3390/ijms27146402}
}
Kostenlos starten →